Related Experiment Video
Updated: Jun 23, 2026

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Endocrine modulation of stimulant use: bidirectional interactions within the hypothalamic-pituitary-gonadal axis
Sally L Huskinson1,2,3, Amy S Kohtz1,2,3
1Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, United States.
Gonadal hormones, like estradiol, progesterone, and testosterone, interact with stimulant use disorders. This relationship is more pronounced in females, suggesting stimulant misuse may be an endocrine disorder, especially in women.
Area of Science:
- Neuroendocrinology
- Addiction Science
- Pharmacology
Background:
- Stimulant use disorders are chronic, relapsing conditions with sex-specific differences.
- Endocrine systems, particularly gonadal hormones, play a critical role in drug vulnerability, escalation, withdrawal, and relapse.
- Existing research highlights bidirectional interactions between gonadal hormones and stimulant reinforcement.
Purpose of the Study:
- To review the bidirectional relationship between gonadal hormones (estradiol, progesterone, testosterone) and stimulant rewards/reinforcement (cocaine, amphetamine, methamphetamine).
- To examine sex differences in the influence of gonadal hormones on stimulant use disorders.
- To highlight the implications for developing individualized pharmacotherapies for stimulant misuse.
Main Methods:
- Literature review focusing on studies examining gonadal hormones and stimulant use.
- Analysis of research involving rodents, nonhuman primates, and humans.
- Comparison of findings across different stimulant types (cocaine, amphetamine, methamphetamine).
Main Results:
- The relationship between gonadal hormones and stimulant reinforcement is robust in female rodents but mixed in female nonhuman primates and women.
- Variability in menstrual cycles and ovarian hormone levels contributes to mixed results in primates and humans.
- The influence of gonadal hormones on stimulant reinforcement appears less consistent in males compared to females.
Conclusions:
- Stimulant misuse can be viewed as an endocrine disorder, particularly in females, due to reciprocal interactions between neural and hormone systems.
- Understanding the hypothalamic-pituitary-gonadal (HPG) axis is crucial for sex-specific treatment of stimulant use disorders.
- Individualized pharmacotherapies for stimulant misuse, especially for women, require consideration of these hormonal interactions.
More Related Videos
Related Concept Videos
Regulation of Hormone Secretion
Humoral stimuli,...
Hypothalamic-Pituitary Axis
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...

